LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ET
Company Participants
Dorian LeBlanc – CFO
George LeMaitre – CEO
Dave Roberts – President
Conference Call Participants
Suraj Kalia – Oppenheimer
Michael Petusky – Barrington Research
Rick Wise – Stifel
Michael Saccone – Jefferies
Frank Tarkinen – Lake Street
Jim Sidoti – Sidoti & Company
Brett Fishbin – KeyBanc Capital Markets
Ross Osborne – Cantor Fitzgerald
Danny Stauder – Citizens JMP
Operator
Welcome to the LeMaitre Vascular First Quarter 2025 Financial Results Conference Call. [Operator Instructions]. I would like to turn the call over to Mr. Dorian LeBlanc, Chief Financial Officer of LeMaitre Vascular. Please go ahead, sir.
Dorian LeBlanc
Thank you operator. Good afternoon, and thank you for joining us on our Q1 2025 conference call. With me on today’s call is our CEO, George LeMaitre and our President, Dave Roberts. Before we begin, I’ll read our Safe Harbor statement. Today we will make some forward looking statements within the meeting of the US, private security litigation reform act of 1995 the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify these forward looking statements by using words such as, believe, expect, anticipate, pursue, forecast and similar expressions. Our forward looking statements are based on our estimates and assumptions as of today May 1, 2025 and should not be relied upon as representing our estimates or views on any subsequent date. Please refer to the cautionary statement regarding forward looking information and the risk factors in our most recent 10k and subsequent SEC filings, including disclosure of the factors that could cause results to differ materially from those expressed or implied. During this call, we will discuss non-GAAP financial measures such as organic sales growth, a reconciliation of GAAP to non-GAAP measures discussed in this call is contained in the associated press release and is available in the investor relations